可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Hansen JF,Denmark H. Coronary collateral circulation: Clinical significance and influence on survival in patients with coronary artery occlusion[J]. Am Heart J , 1989, 117: 290.
[2]Ware JA , Simons M. Angiogenesis in ischemic heart disease[J].Nature Med , 1997, 73: 158.
[3] Saito Y, Yasuno M , Ishido M , et al. Importance of coronary collaterals for restoration of left ventricular function after intracoronary thrombolysis[J]. Am J Cardiol, 1985, 55: 1259.
[4] Fuster V , Frye RL , Kennedy MA , et al. The role of collateral circulation in various coronary syndrome[J]. Circulation, 1979,59: 1137.
[5] James TN. The delivery and distribution of coronary collateral circulation[J]. Chest, 1970, 58: 183.
[6] Pellinen TJ ,Virtanen KS, Toivonen L , et al. Coronary collateral circulation[J]. Clin Cardiol, 1991, 14: 111.
[7] Schaper W , Ito WD. Molecular mechanisms of coronary collateral vessel growth [J]. Circ Res, 1996, 79: 911.
[8] Pasky S, Schaper W , Schaper J , et al. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog[J]. Am J Physiol, 1982, 242: H1031.
[9] Kass PW , Kotler MN , Yazdanfar S. Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications[J]. Am Heat J , 1992, 123: 486.
[10]Losordo DW ,Vale PR, Isner JM. Gene therapy for myocardial angiogenesis[J]. Am Heart J , 1999, 138: S132.
[11]王乐民, 李相忠. 酸性纤维细胞生长因子の虚血心脏に对する组织修复作用[J]. 组织培养研究, 1993, 12: 247.
[12]王乐民, 张建军. 大鼠梗塞心肌修复期酸性成纤维细胞生长因子的免疫组化研究[J].中华心血管病杂志, 1994, 4 (2) : 142.
[13]Hariwala M , Horowitz JR, Esakof D, et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts[J]. J Surg Res, 1996, 63: 77.
[14] Magovern CJ , Mack CA , Zhang J , et al. Direct in vivo gene transfer canine myocardium using a rep lication-deficient adenovirus vector [J]. Ann Thorac Surg , 1996, 62: 421.
[15]Mack CA , Patel SR, Schwarz EA , et al. Biological bypass with use of adenovirus-mediating gene transfer of the complementary ovyribonucleic acid for vascular endothelial growth factor 121 improves myocardium perfusion and function in the ischemic porcine heart [J]. J Thorac Cardiovasc Surg , 1998, 115: 168.
[16] Schumacher B, Pecher P, Vonspecht BU , et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease[J]. Circulation, 1998, 97: 645.
[17] Fujita M , Sasayama S, Asanio H, et al. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina[J]. Circulation, 1988, 77: 1022.
[18]Uchida Y, Yanagisawa-Miwa A ,Nakamura F, et al. Angiogenic injection of basic fibroblast growth factor and heparin sulfate:an experimental study[J]. Am Heart J , 1995, 130: 1182.
[19]Ejiri M , Fjia M ,Miwa K, et al. Effects of heparin treatment on collateral development and regional myocardial function in acute myocardial infarction[J]. Am Heart J , 1990, 119: 248.